Correlation Between Capricor Therapeutics and GH Research
Can any of the company-specific risk be diversified away by investing in both Capricor Therapeutics and GH Research at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Capricor Therapeutics and GH Research into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Capricor Therapeutics and GH Research PLC, you can compare the effects of market volatilities on Capricor Therapeutics and GH Research and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Capricor Therapeutics with a short position of GH Research. Check out your portfolio center. Please also check ongoing floating volatility patterns of Capricor Therapeutics and GH Research.
Diversification Opportunities for Capricor Therapeutics and GH Research
0.24 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Capricor and GHRS is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding Capricor Therapeutics and GH Research PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GH Research PLC and Capricor Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Capricor Therapeutics are associated (or correlated) with GH Research. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GH Research PLC has no effect on the direction of Capricor Therapeutics i.e., Capricor Therapeutics and GH Research go up and down completely randomly.
Pair Corralation between Capricor Therapeutics and GH Research
Given the investment horizon of 90 days Capricor Therapeutics is expected to under-perform the GH Research. But the stock apears to be less risky and, when comparing its historical volatility, Capricor Therapeutics is 1.89 times less risky than GH Research. The stock trades about -0.02 of its potential returns per unit of risk. The GH Research PLC is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest 750.00 in GH Research PLC on December 28, 2024 and sell it today you would earn a total of 475.00 from holding GH Research PLC or generate 63.33% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Capricor Therapeutics vs. GH Research PLC
Performance |
Timeline |
Capricor Therapeutics |
GH Research PLC |
Capricor Therapeutics and GH Research Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Capricor Therapeutics and GH Research
The main advantage of trading using opposite Capricor Therapeutics and GH Research positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Capricor Therapeutics position performs unexpectedly, GH Research can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GH Research will offset losses from the drop in GH Research's long position.Capricor Therapeutics vs. NextCure | Capricor Therapeutics vs. Pulmatrix | Capricor Therapeutics vs. Akari Therapeutics PLC | Capricor Therapeutics vs. Soleno Therapeutics |
GH Research vs. Molecular Partners AG | GH Research vs. MediciNova | GH Research vs. Anebulo Pharmaceuticals | GH Research vs. Champions Oncology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |